G protein-coupled receptors as targets for approved drugs: How many targets and how many drugs?

Molecular Pharmacology

Volumn 93, Issue 4, 2018, Pages 251-258

  Sriram, Krishna ^a   Insel, Paul A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; G PROTEIN COUPLED RECEPTOR;

CONFERENCE PAPER; DRUG APPROVAL; DRUG TARGETING; EUROPEAN UNION; FOOD AND DRUG ADMINISTRATION; HUMAN; PRIORITY JOURNAL; UNITED STATES; ANIMAL; DRUG DELIVERY SYSTEM; FACTUAL DATABASE; METABOLISM; PROCEDURES; TRENDS;

ANIMALS; DATABASES, FACTUAL; DRUG DELIVERY SYSTEMS; HUMANS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85042615298     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.117.111062     Document Type: Conference Paper

References (28)

1. Alexander SPH, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, et al.; CGTP Collaborators (2017) The concise guide to pharmacology 2017/18: overview. Br J Pharmacol 174 (Suppl 1): S1-S16.
2. Allen JA and Roth BL (2011) Strategies to discover unexpected targets for drugs active at G protein-coupled receptors. Annu Rev Pharmacol Toxicol 51:117-144.
3. Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Krüger FA, Light Y, Mak L, McGlinchey S, et al. (2014) The ChEMBL bioactivity database: An update. Nucleic Acids Res 42:D1083-D1090.
4. Chambers J, Davies M, Gaulton A, Hersey A, Velankar S, Petryszak R, Hastings J, Bellis L, McGlinchey S, and Overington JP (2013) UniChem: A unified chemical structure cross-referencing and identifier tracking system. J Cheminform 5:3.
5. Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, Johnston SE, Vrcic A, Wong B, Khan M, et al. (2017) The Drug Repurposing Hub: A nextgeneration drug library and information resource. Nat Med 23:405-408.
6. Cotto KC, Wagner AH, Feng YY, Kiwala S, Coffman AC, Spies G, Wollam A, Spies NC, Griffith OL, and Griffith M. (2017) DGIdb 3.0: A redesign and expansion of the drug-gene interaction database. Nucleic Acids Res, in press.
7. Feelders RA, Yasothan U, and Kirkpatrick P (2012) Pasireotide. Nat Rev Drug Discov 11:597-598.
8. Gong R (2014) Leveraging melanocortin pathways to treat glomerular diseases. Adv Chronic Kidney Dis 21:134-151.
9. Hebert SC, Mount DB, and Gamba G (2004) Molecular physiology of cation-coupled Cl- cotransport: The SLC12 family. Pflugers Arch 447:580-593.
10. Huang XP, Karpiak J, Kroeze WK, Zhu H, Chen X, Moy SS, Saddoris KA, Nikolova VD, Farrell MS, Wang S, et al. (2015a) Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature 527:477-483.
11. Huang Y, Skwarek-Maruszewska A, Horré K, Vandewyer E, Wolfs L, Snellinx A, Saito T, Radaelli E, Corthout N, Colombelli J, et al. (2015b) Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models. Sci Transl Med 7:309ra164.
12. Hutchings CJ, Koglin M, Olson WC, and Marshall FH (2017) Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat Rev Drug Discov 16:787-810.
13. Insel PA, Wilderman A, Zambon AC, Snead AN, Murray F, Aroonsakool N, McDonald DS, Zhou S, McCann T, Zhang L, et al. (2015) G protein-coupled receptor (GPCR) expression in native cells: "Novel" endoGPCRs as physiologic regulators and therapeutic targets. Mol Pharmacol 88:181-187.
14. Jahny E, Yang H, Liu B, Jahnke B, Lademann F, Knösel T, Rümmele P, Grützmann R, Aust DE, Pilarsky C, et al. (2017) The G protein-coupled receptor RAI3 is an independent prognostic factor for pancreatic cancer survival and regulates proliferation via STAT3 phosphorylation. PLoS One 12:e0170390.
15. Patel HH and Ostrom RS (2008) An orphan GPCR finds a home in the heart. Am J Physiol Heart Circ Physiol 295:H479-H481.
16. Pera T, Deshpande DA, Ippolito M, Wang B, Gavrila A, Michael JV, Nayak AP, Tompkins E, Farrell E, Kroeze WK, et al (2017) Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines. FASEB J DOI:10.1096/fj.201700555R [published ahead of print].
17. Rask-Andersen M, Masuram S, and Schiöth HB (2014) The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication. Annu Rev Pharmacol Toxicol 54:9-26.
18. Rebhan M, Chalifa-Caspi V, Prilusky J, and Lancet D (1998) GeneCards: A novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics 14:656-664.
19. Rimkus TK, Carpenter RL, Qasem S, Chan M, and Lo HW (2016) Targeting the sonic hedgehog signaling pathway: Review of smoothened and GLI inhibitors. Cancers (Basel) 8:22.
20. Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al- Lazikani B, Hersey A, Oprea TI, et al. (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16:19-34.
21. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SPH, Buneman OP, Davenport AP, McGrath JC, Peters JA, et al.; NC-IUPHAR (2016) The IUPHAR/BPS Guide to Pharmacology in 2016: Towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res 44:D1054-D1068.
22. The UniProt Consortium (2017) UniProt: The universal protein knowledgebase. Nucleic Acids Res 45:D158-D169.
23. Wacker D, Stevens RC, and Roth BL (2017) How ligands illuminate GPCR molecular pharmacology. Cell 170:414-427.
24. Wiley SZ, Sriram K, Liang W, Chang SE, French R, McCann T, Sicklick J, Nishihara H, Lowy AM, and Insel PA (2017) GPR68, a proton-sensing GPCR, mediates interaction of cancer associated fibroblasts and cancer cells. FASEB J [published ahead of print].
25. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, and Hassanali M (2007) DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36:D901-D906.
26. Xie H and He SH (2005) Roles of histamine and its receptors in allergic and inflammatory bowel diseases. World J Gastroenterol 11:2851-2857.
27. Yang Y, Fu A, Wu X, and Reagan JD (2012) GPR35 is a target of the loop diuretic drugs bumetanide and furosemide. Pharmacology 89:13-17.
28. Ye X, Tao Q, Wang Y, Cheng Y, and Lotan R (2009) Mechanisms underlying the induction of the putative human tumor suppressor GPRC5A by retinoic acid. Cancer Biol Ther 8:951-962.